Taiwanese voice actress, Chiang Tu-hui, who lent her voice for Shin-chan dies at the age of 49


One of the most popular characters in the cartoon world might not be heard anymore for the Taiwanese audience. We are talking about anime characters such as Crayon Shin-chan and Chibi Maruko-Chan. This is because of the fact that the voice actress behind these characters has died. Chiang Tu-hui, the voice actress who lent her voice for these anime characters, has died aged 49 on the morning of September 16 we have learnt.

On the morning of Monday, it was revealed on Facebook that the popular voice actress has died. The announcement was made on the Facebook page AV Voices where they gave this sad news. The page posted that “Ms. Chiang Tu-hui left us this morning, and we will always miss you.”. Soon after the post was uploaded, many fans expressed their disbelief and shock over the news and shared their condolences.

Taipei Dubbing Union also confirmed the news of Chiang’s death with the media. The Union said that Chiang died on Monday morning at 7:13 a.m. at the age of 49. While the Taipei Dubbing Union did not reveal anything regarding the cause of her death, it was reported that she was diagnosed with stage 4 cervical cancer. The cause of her death has been revealed to be multiple organ failure.

In Taiwan, Chian was extremely popular as she has lent her voice to anime characters such as “Crayon Shin-chan,” “Chibi Maruko-chan,” “Naruto,” “Detective Conan,” “Attack on Titan,” and “Yu Yu Hakusho”. Not only Japanese animes, Chiang has also given her voice for Taiwanese films such as “Barkley the Cat” and “Silent Code.”

A lot of fans in Taiwan were impressed by Chian’s professional skills as well as dedicated attitude towards her work. She was often seen on Taiwan national TV making public appearances. She also shared her craft of voice acting which everyone loved.

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More